Clinicopathological Significance of Exosomal Proteins CD9 and CD63 and DNA Mismatch Repair Proteins in Prostate Adenocarcinoma and Benign Hyperplasia.
Kristofs FolkmanisElizabete JunkEvelina MerdaneInese FolkmaneValdis FolkmanisIgors IvanovsJanis EglitisMaris JakubovskisSven LaabsSergejs IsajevsVilnis LietuvietisPublished in: Diagnostics (Basel, Switzerland) (2022)
CD9 protein expression was downregulated in PCa, compared to BPH, while CD63 protein expression was upregulated in high-grade PCa but downregulated in low-grade PCa. CD63 protein upregulation, CD9 downregulation, and loss of MMR protein characterized the shorter PFS of high-grade PCa patients. CD9, CD63, and MMR could be the routine immunohistochemical biomarkers for the diagnosis and risk stratification of PCa.